Company intelligence / Profile preview
Bruno Farmaceutici
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
Overview
Bruno Farmaceutici is an Italian commercial-stage pharmaceutical company marketing prescription and generic small‑molecule medicines (notably oral corticosteroids and anti‑diabetes drugs) and nutritional supplements across multiple therapeutic areas, with ongoing internal R&D focused on new formulations for osteoporosis, pain, cardiology, diabetes, obesity, and alcohol addiction.
- Therapeutic areas
- OtherEndocrinologyCardiovascularNeurologyInfectious DiseasesRheumatologyMetabolic DisordersPsychiatry
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Bruno Farmaceutici.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bruno Farmaceutici.